Patents by Inventor Walter Kamm

Walter Kamm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20230181739
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: November 11, 2022
    Publication date: June 15, 2023
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Liquid pharmaceutical composition
    Patent number: 11590206
    Abstract: The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: February 28, 2023
    Assignee: SANOFI
    Inventors: Marta Venczel, Nino Meyer, Walter Kamm, Norbert Nagel, Bruno Baumgartner
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20230049480
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: July 14, 2022
    Publication date: February 16, 2023
    Inventors: Oliver BLEY, Petra LOOS, Bernd BIDLINGMAIER, Walter KAMM, Harald BERCHTOLD
  • LIQUID PHARMACEUTICAL COMPOSITION
    Publication number: 20220160837
    Abstract: The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 26, 2022
    Inventors: Marta VENCZEL, Nino MEYER, Walter KAMM, Norbert NAGEL, Bruno BAUMGARTNER
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20220040267
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: July 3, 2021
    Publication date: February 10, 2022
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART
    Publication number: 20220023392
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Application
    Filed: July 3, 2021
    Publication date: January 27, 2022
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20210077589
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: August 25, 2020
    Publication date: March 18, 2021
    Inventors: Oliver BLEY, Petra LOOS, Bernd BIDLINGMAIER, Walter KAMM, Harald BERCHTOLD
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20200297852
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: February 26, 2020
    Publication date: September 24, 2020
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 10610595
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: April 7, 2020
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Otamixaban formulations with improved stability
    Patent number: 9993464
    Abstract: The invention relates to a pharmaceutical composition comprising methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: June 12, 2018
    Assignee: SANOFI
    Inventors: Walter Kamm, Till Bussemer, Doris Andert, Bernd Kuehn, Ernst-Josef Todt
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20180125945
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: October 10, 2017
    Publication date: May 10, 2018
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART
    Publication number: 20180125944
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Application
    Filed: October 6, 2017
    Publication date: May 10, 2018
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20180125943
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: October 6, 2017
    Publication date: May 10, 2018
    Inventors: Oliver BLEY, Petra LOOS, Bernd BIDLINGMAIER, Walter KAMM, Harald BERCHTOLD
  • STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
    Publication number: 20180125981
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: October 13, 2017
    Publication date: May 10, 2018
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin aspart
    Patent number: 9895423
    Abstract: Stabilized pharmaceutical formulations of insulin aspart are disclosed.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: February 20, 2018
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 9895424
    Abstract: Stabilized pharmaceutical formulations of insulin analogs and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: February 20, 2018
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 9839692
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: December 12, 2017
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
    Patent number: 9839675
    Abstract: Stabilized pharmaceutical formulations of insulin analogs and/or insulin derivatives are disclosed.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: December 12, 2017
    Assignee: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold
  • OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY
    Publication number: 20170224668
    Abstract: The invention relates to a pharmaceutical composition comprising methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino} butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
    Type: Application
    Filed: September 14, 2016
    Publication date: August 10, 2017
    Inventors: Walter KAMM, Till BUSSEMER, Doris ANDERT, Bernd KUEHN, Ernst-Josef TODT
  • Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives
    Publication number: 20150216981
    Abstract: Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.
    Type: Application
    Filed: January 8, 2015
    Publication date: August 6, 2015
    Applicant: SANOFI
    Inventors: Oliver Bley, Petra Loos, Bernd Bidlingmaier, Walter Kamm, Harald Berchtold